Select Publications
Book Chapters
2023, 'Glutamate in the Pathogenesis of Gliomas', in Handbook of Neurotoxicity, Second Edition, pp. 2029 - 2041, http://dx.doi.org/10.1007/978-3-031-15080-7_149
,2023, 'Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disease', in Handbook of Neurotoxicity, Second Edition, pp. 747 - 768, http://dx.doi.org/10.1007/978-3-031-15080-7_126
,2022, 'Assay of Fatty Acids and Their Role in the Prevention and Treatment of COVID-19', in Multiplex Biomarker Techniques: Methods and Applications for COVID-19 Disease Diagnosis and Risk Stratification, Springer US, New York, NY, USA, pp. 213 - 234, http://dx.doi.org/10.1007/978-1-0716-2395-4_16
,2022, 'Glutamate in the Pathogenesis of Gliomas', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 13, http://dx.doi.org/10.1007/978-3-030-71519-9_149-1
,2022, 'Ionotropic Receptors in the Central Nervous System and Neurodegenerative Disease', in Handbook of Neurotoxicity, Springer International Publishing, pp. 1 - 22, http://dx.doi.org/10.1007/978-3-030-71519-9_126-1
,2020, 'Clinical Assessment of the NADome as Biomarkers for Healthy Aging', in Guest PC (ed.), Clinical and Preclinical Models for Maximizing Healthspan Methods and Protocols, Humana, pp. 207 - 216, http://dx.doi.org/10.1007/978-1-0716-0471-7_13
,2020, 'Quantitative Assays of Plasma Apolipoproteins', in Guest PC (ed.), Clinical and Preclinical Models for Maximizing Healthspan. Methods in Molecular Biology, Humana, New York, NY, USA, pp. 49 - 81, http://dx.doi.org/10.1007/978-1-0716-0471-7_3
,2017, 'Natural Plant-Derived Acetylcholinesterase Inhibitors: Relevance for Alzheimer's Disease', in Andrade PB; Valentao P; Pereira DM (ed.), Natural Products Targeting Clinically Relevant Enzymes, Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany, pp. 297 - 318, http://dx.doi.org/10.1002/9783527805921.ch12
,2014, 'Drug Treatments for Alzheimer’s Disease: Hopes and Challenges', in Kostrzewa RM (ed.), Handbook for Neurotoxicity, Springer, New York, USA, pp. 1173 - 1190, http://dx.doi.org/10.1007/978-1-4614-5836-4_141
,2014, 'Glutamate in the Pathogenesis of Gliomas', in Kostrzewa RM (ed.), Handbook of Neurotoxicity, Springer, New York, USA, pp. 1287 - 1298, http://dx.doi.org/10.1007/978-1-4614-5836-4_149
,2014, 'Ionotropic receptors in the central nervous system and neurodegenerative disease', in Kostrzewa RM (ed.), Handbook for Neurotoxicity, Springer, New York, USA, pp. 1071 - 1092, http://dx.doi.org/10.1007/978-1-4614-5836-4_126
,Journal articles
2024, 'Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personality', Neuroscience and Biobehavioral Reviews, 158, http://dx.doi.org/10.1016/j.neubiorev.2024.105570
,2024, 'Fluid biomarkers of the neurovascular unit in cerebrovascular disease and vascular cognitive disorders: A systematic review and meta-analysis', Cerebral Circulation - Cognition and Behavior, 6, http://dx.doi.org/10.1016/j.cccb.2024.100216
,2024, 'The protocol for an observational Australian cohort study of CADASIL: The AusCADASIL study', Cerebral Circulation - Cognition and Behavior, 6, http://dx.doi.org/10.1016/j.cccb.2024.100225
,2023, 'Molecular biomarkers for vascular cognitive impairment and dementia', Nature Reviews Neurology, 19, pp. 737 - 753, http://dx.doi.org/10.1038/s41582-023-00884-1
,2023, 'Association of omega 3 polyunsaturated fatty acids with incident chronic kidney disease: pooled analysis of 19 cohorts', BMJ, http://dx.doi.org/10.1136/bmj-2022-072909
,2020, 'Hormetic effects of alcohol in an astroglial cellular model and its proteomics signature', Alzheimer's & Dementia, 16, http://dx.doi.org/10.1002/alz.041665
,2019, 'The Precursor to Glutathione (GSH), γ-Glutamylcysteine (GGC), Can Ameliorate Oxidative Damage and Neuroinflammation Induced by Aβ40 Oligomers in Human Astrocytes', Frontiers in Aging Neuroscience, 11, pp. 1 - 1, http://dx.doi.org/10.3389/fnagi.2019.00177
,2019, 'Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes', Antioxidants and Redox Signaling, 30, pp. 251 - 294, http://dx.doi.org/10.1089/ars.2017.7269
,2018, 'Quantifying the cellular NAD+ metabolome using a tandem liquid chromatography mass spectrometry approach', Metabolomics, 14, http://dx.doi.org/10.1007/s11306-017-1310-z
,2017, 'Corrigendum: Identification of cerebral metal ion imbalance in the brain of ageing octodon degus [Front. Aging Neurosci., 9, (2017) (66)] DOI: 10.3389/fnagi.2017.00066', Frontiers in Aging Neuroscience, 9, pp. 134, http://dx.doi.org/10.3389/fnagi.2017.00134
,2017, 'Identification of cerebral metal ion imbalance in the brain of ageing Octodon degus', Frontiers in Aging Neuroscience, 9, pp. 66 - 66, http://dx.doi.org/10.3389/fnagi.2017.00066
,2017, 'Molecular targets of Tannic Acid in Alzheimer’s disease', Curr Alzheimer Res, 14, http://dx.doi.org/10.2174/1567205014666170206163158
,2016, 'Application of targeted mass spectrometry for the quantification of sirtuins in the central nervous system', Scientific Reports, 6, pp. 35391 - 35391, http://dx.doi.org/10.1038/srep35391
,2016, 'Resveratrol as a potential therapeutic candidate for the treatment and management of alzheimer’s disease', Current Topics in Medicinal Chemistry, 16, pp. 1951 - 1960, http://dx.doi.org/10.2174/1568026616666160204121431
,2015, 'Differential expression of sirtuins in the aging rat brain', Frontiers in Cellular Neuroscience, 9, pp. 167, http://dx.doi.org/10.3389/fncel.2015.00167
,2015, 'Upregulation of glycolytic enzymes, mitochondrial dysfunction and increased cytotoxicity in glial cells treated with Alzheimer's disease plasma', PLoS ONE, 10, pp. e0116092, http://dx.doi.org/10.1371/journal.pone.0116092
,2015, 'Accelerating Alzheimer's research through 'natural' animal models', Current Opinion in Psychiatry, 28, pp. 155 - 164, http://dx.doi.org/10.1097/YCO.0000000000000137
,2014, 'Mapping NAD+ metabolism in the brain of ageing Wistar rats: potential targets for influencing brain senescence', Biogerontology, 15, pp. 177 - 198, http://dx.doi.org/10.1007/s10522-013-9489-5
,2014, 'Metal and complementary molecular bioimaging in alzheimer's disease', Frontiers in Aging Neuroscience, 6, pp. 138, http://dx.doi.org/10.3389/fnagi.2014.00138
,2013, 'The role of polyphenols in the modulation of sirtuins and other pathways involved in Alzheimer's disease', Ageing Research Reviews, 12, pp. 867 - 883, http://dx.doi.org/10.1016/j.arr.2013.06.003
,2012, 'Sirtuins in cognitive ageing and Alzheimer's disease', Current Opinion in Psychiatry, 25, pp. 226 - 230, http://dx.doi.org/10.1097/YCO.0b013e32835112c1
,2011, 'P1‐115: Plasma apolipoproteins as biomarkers of mild cognitive impairment in a community‐based sample', Alzheimer's & Dementia, 7, http://dx.doi.org/10.1016/j.jalz.2011.05.394
,2009, 'Effects of Kynurenine Pathway Metabolites on Intracellular NAD+ Synthesis and Cell Death in Human Primary Astrocytes and Neurons', International Journal of Tryptophan Research : IJTR, 2, pp. 61 - 69
,2007, 'Membrane permeability of redox active metal chelators: An important element in reducing hydroxyl radical induced NAD(+) depletion in neuronal cells', Neuroscience Research, 57, pp. 454 - 461
,Conference Abstracts
2017, 'Sirtuin protein and related energy metabolite changes in the Alzheimer brain [Poster Abstract P2-182]', in Alzheimer's and Dementia, Elsevier, London, UK, Vol. 13, pp. P676 - P676, presented at lzheimer's Association International Conference (AAIC) 2017, London, UK, 16 July 2017 - 20 July 2017, http://dx.doi.org/10.1016/j.jalz.2017.06.833
,2013, 'Development of a targeted mass spectrometry method for accurate quantification of human sirtuins in biological samples [Abstract P2-035]', in Alzheimer's & Dementia, Boston, MA, USA, Vol. 9, pp. P357 - P357, presented at Alzheimer’s Association International Conference (AAIC) 2013, Boston, MA, USA, 13 July 2013 - 18 July 2013, http://dx.doi.org/10.1016/j.jalz.2013.05.677
,2012, 'NAD+ metabolism, and oxidative stress in the brain of aging Wistar rats: Is there a link? [Abstract P3-073]', in Alzheimer's & Dementia, Vancouver, Canada, Vol. 8, pp. P478 - P478, presented at Alzheimer’s Association International Conference (AAIC) 2012, Vancouver, Canada, 14 July 2012 - 19 July 2012, http://dx.doi.org/10.1016/j.jalz.2012.05.1292
,2012, 'Sirtuin expression during aging and in Alzheimer's disease [Abstract P2-094]', in Alzheimer's & Dementia, Vancouver, Canada, Vol. 8, pp. P295 - P296, presented at Alzheimer’s Association International Conference (AAIC) 2012, Vancouver, Canada, 14 July 2012 - 19 July 2012, http://dx.doi.org/10.1016/j.jalz.2012.05.798
,2010, 'Screening plasma for biomarkers of mild cognitive impairment and Alzheimer's disease by quantitative proteomic methods [Abstract O3-03-03]', in Alzheimer's & Dementia, Honolulu, Hawaii, USA, Vol. 6, pp. S129 - S130, presented at Alzheimer’s Association International Conference (AAIC) 2010, Honolulu, Hawaii, USA, 10 July 2010 - 15 July 2010, http://dx.doi.org/10.1016/j.jalz.2010.05.406
,2009, 'Diagnostic biomarkers of mild cognitive impairment and Alzheimer's disease: A plasma proteomics approach [Oral Abstract]', in Australasian Journal of Ageing, Canberra, Vol. 28, pp. A71 - A72, presented at 42nd National Conference of the Australian Association of Gerontology, Canberra, 25 November 2009 - 27 November 2009, http://dx.doi.org/10.1111/j.1741-6612.2009.00397.x
,